Dr. Suparno Chakrabati

Dr. Suparno Chakrabati

Head of Department (HOD)

36 Years of Experience

Bone Marrow Transplant Surgeon, Hemato-Oncologist

MBBS, MD, DM, FRCP

Dharamshila Narayana Superspeciality Hospital, New Delhi

English, Hindi

Consultation Fee ₹ 600

Book an Appointment

About Dr. Suparno Chakrabati

  • Dr. Suparno Chakrabati is an experienced hemato-oncologist.
  • He has over 36 years of experience in hematology and expertise in bone marrow transplantation.
  • Dr. Chakrabati is highly skilled in providing specialized treatments in hemato-oncology, stem cell transplant, haploidentical BMT, and post-transplant viral infections.
  • His educational qualifications include an MBBS from RG Kar Medical College and Hospital, Kolkata, in 1988 and an MD in General Medicine from Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, in 1997.
  • Later, he pursued a DM in Hematopoietic Stem Cell Transplantation from University of Birmingham, London, in 2004.
  • Dr. Chakrabati has been welcomed to address talks on a variety of topics around the world and was nominated by the Expert Committee for European and International Bone Marrow Transplant Organizations.
  • He is a member of the American Society of Hematology, the British Society of Hematology, the American Society of Blood and Marrow Transplantation, and the British Society of Blood and Marrow Transplantation.
  • Dr. Chakrabati has authored more than 100 scientific articles in the most prestigious journals.
  • He is on the editorial board of Current Cell Research & Therapy, Advances in Hematology, and Med J. Hematol Infect.
  • Dr. Chakrabati has established the Manashi Chakrabarti Foundation, a charitable organization that aids kids with blood disorders in memory of his late mother.

Book Your Appointment With Dr. Suparno Chakrabati

Get a Treatment Plan Within 1 Hour

Education

  • MBBS, RG Kar Medical College and Hospital, Kolkata, 1988
  • MD - General Medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 1997
  • DM - Hematopoietic Stem Cell Transplantation, University of Birmingham, London, 2004
  • Fellow of Royal College Of Pathologists (FRCP), London, UK

Training & Certificates

  • Training - Hematology and BMT, CMCH, Vellore

Past Experience

  • Director, Apollo, Gleneagles Hospital, Kolkata, 2013
  • Principal Consultant, St.George Hospital, London, 2009
  • Director, Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, 2008
  • Principal Consultant, City Hospital Birmingham, 2003

Associations/Membership

  • American Society of Haematology
  • British Society of Haematology
  • British Society of Blood and Marrow Transplantation
  • American Society of Blood and Marrow Transplantation
  • A working party of Infectious Disease of the European Blood and Marrow Transplantation Society

Paper Published

Dr. Suparno Chakrabati has over 100 scientific publications in top-rated and highly regarded journals. Some of his scientific publications include:

  • Kottaridis, P. D., Chakrabarti, S., Milligan, D. W., Chopra, R., Chakraverty, R. K., Robinson, S., et al. (2000). In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood, The Journal of the American Society of Hematology, 96(7), 2419–2425.
  • Chakrabarti, S., Lees, A., Jones, S. G., & Milligan, D. W. (2000). Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone marrow transplantation, 26(8), 871–876.
  • Chakrabarti, S., Collingham, K. E., Fegan, C. D., & Milligan, D. W. (1999). Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplantation, 23(11), 1209-1211.
  • Chakrabarti, S., Mautner, V., Osman, H., Collingham, K. E., Fegan, C. D., Klapper, P. E., Milligan, D. W., et al. (2002). Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood, The Journal of the American Society of Hematology, 100(5), 1619-1627.

Field of Expertise

  • Allogeneic Bone Marrow Transplant
  • Autologous Bone Marrow Transplant
  • Haplo–Allogeneic Bone Marrow Transplant
  • Hematopoietic Stem Cell Transplantation (HPSCT)
  • Pediatric Bone Marrow Transplant
  • Stem Cell Transplant
  • Anemia
  • Aplastic Anemia
  • Chronic Granulomatous Disease (CGD)
  • Diamond-Blackfan Anemia (DBA)
  • Dyskeratosis Congenita (DKC)
  • Eosinophilic Disorders
  • Essential Thrombocythemia
  • Fanconi Anemia (FA)
  • Hemochromatosis
  • Hemolytic Anemia
  • Hemophilia
  • Hereditary Spherocytosis
  • Hodgkin Lymphoma
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Inherited Bone Marrow Failure Syndromes (IBMFS)
  • Iron-Deficiency Anemia
  • Langerhans Cell Histiocytosis (LHC)
  • Leukopenia
  • Mastocytosis
  • Monoclonal Gammopathy
  • Myelodysplastic Syndromes (MDS)
  • Myelofibrosis
  • Myeloproliferative Neoplasms (MPN)
  • Non-Hodgkin Lymphoma
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pernicious Anemia
  • Polycythemia Vera
  • Porphyria
  • Post-Transplant Lymphoproliferative Disorder (PTLD)
  • Shwachman-Diamond syndrome (SDS)
  • Sickle Cell Anemia
  • Thalassemia
  • Thrombocytopenia
  • Thrombophilia
  • Thrombotic Thrombocytopenic Purpura (TTP)
  • Venous Thromboembolism (VTE)
  • Von Willebrand Disease
  • Waldenstrom Macroglobulinemia

Blogs

Guide to Health and Wellness

Best Hematology Doctors in India